Ottawa has signed two deals to acquire 1.5 million pills to treat the worst symptoms of COVID-19.
• Read also: COVID-19 self-test for Quebecers until Christmas
• Read also: Omicron reports 38 countries but no deaths so far, says WHO
The first agreement, concluded with Pfizer, which has already supplied a large portion of the vaccines received in the country, provides for the arrival of one million of these oral treatments, said Philomena Tasi, Minister of Supply, on Friday. to be confirmed.
The second is linked to the Merck company, with which Ottawa has agreed for the first delivery of 500,000 capsules, with the option of receiving 500,000 more if necessary.
“While vaccines play an important role in preventing the spread and severity of cases, other treatment options are needed to help reduce the burden of COVID-19,” said Marwan Akar, President and CEO of Merck Canada.
Note that none of these products have yet been approved by Health Canada, but the government is preparing to distribute them to the provinces as soon as they are approved by public health.
2.9 million doses for children
Canada has received a total of 2.9 million doses of the COVID-19 vaccine, designed specifically for children between the ages of 5 and 11.
The number of doses currently in stock is “enough to vaccinate all eligible children across the country,” announced Minister Tasi.
The messenger RNA concentration in these COVID-19 vaccines is three times lower than in vaccines for people 12 years of age and older.
Analyst. Amateur problem solver. Wannabe internet expert. Coffee geek. Tv guru. Award-winning communicator. Food nerd.